OrbusNeich Receives ISO 14001 and ISO 45001 Certifications for Shenzhen Production and Research & Development Site

(Hong Kong, June 18, 2024) – OrbusNeich Medical Group Holdings Limited (“OrbusNeich” or the “Group”; stock code: 6929), a major global medical device manufacturer specializing in interventional devices for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures, announced today that its manufacturing and R&D site in Shenzhen, China has been awarded the ISO 14001 and ISO 45001 certifications. This marks that we have reached international standards in occupational health and safety as well as environmental management.

ISO 14001 is the international standard for environmental management systems, recognizing organizations that have implemented effective processes to minimize their environmental impact. ISO 45001 is the global standard for occupational health and safety management, ensuring robust systems are in place to protect workers.

“Obtaining the ISO 14001 and ISO 45001 certifications is a major milestone for OrbusNeich,” said Mr. David Chien, Chairman, Executive Director and Chief Executive Officer of OrbusNeich. “As a company committed to environmental, social, and governance (ESG) excellence, these certifications demonstrate our dedication to operating in a sustainable and responsible manner. We are proud to be an ESG-conscious pioneer in life-changing medical technologies that improve patients’ health outcomes and create a better world.”

The Shenzhen facility manufactures OrbusNeich’s innovative interventional products, which are used around the world. The Shenzhen facility has already established a comprehensive EHS (environment, health and safety) management system, which provides the foundation to maintain workplace safety and ongoing efforts to integrate sustainable practices into business operations, as well as better protect our environment.

OrbusNeich continues to strengthen its ESG initiatives across its global operations through a rigorous approach. In order to create green, safe, and sustainable development, the Group is committed to reducing its carbon footprint, promoting employee well-being, and delivering life-changing technologies that positively impact patient lives.

OrbusNeich Shenzhen Production and Research & Development Site Receives ISO 14001 and ISO 45001 Certifications

－ End －

About OrbusNeich Medical Group Holdings Limited
OrbusNeich is a major global medical device manufacturer specializing in interventional devices for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures. Headquartered in Hong Kong, China, OrbusNeich sells its products in more than 70 countries and regions worldwide. It is also actively expanding into neuro vascular intervention and structural heart disease. As at December 31, 2023, OrbusNeich has more than 240 granted patents and published patent applications worldwide. Its in-house R&D team has more than two decades of product development experience and has developed world-leading proprietary technologies.